NewGenIvf Group is a healthcare services company that provides chromosome screening, embryo transfer, egg freezing, and IVF treatments.
NewGenIvf Group has raised $5.2M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in April 2025.
NewGenIvf Group's investors include JAK Opportunities.
NewGenIvf Group is headquartered in Central, Hong Kong.
NewGenIvf Group is a healthcare services company that provides chromosome screening, embryo transfer, egg freezing, and IVF treatments.
NewGenIvf Group is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"NewGenIvf Group — Funding & Investors." VCBacked, April 3, 2025, https://www.vcbacked.co/company/newgenivf-group. Accessed August 17, 2026.
VCBacked. (2025). NewGenIvf Group — Funding & Investors. Retrieved August 17, 2026, from https://www.vcbacked.co/company/newgenivf-group
{{cite web |title=NewGenIvf Group — Funding & Investors |url=https://www.vcbacked.co/company/newgenivf-group |website=VCBacked |access-date=August 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated